Lower levels of vitamin D are linked to an increased risk of aggressive prostate cancer. Here’s what to know.
Should men with intermediate-risk prostate cancer be offered active surveillance as a treatment? Here’s what new research shows.
How much does it cost to treat men who have low-risk prostate cancer, from the time a patient has his first appointment to follow-up testing years later?